Details of Bacterial Vaccine
This bacterial vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 1346 |
| Name of the vaccine | GSK513026 |
| Microbe | Bacteria |
| Disease name | Pneumococcal |
| Name of bacteria | Streptococcus pneumoniae |
| Type of vaccine | NA |
| Nucleic acid content | DNA |
| Age | 65 years and older |
| Description of the vaccine | Pneumococcal protein vaccine. |
| Name of the manufacturer | GlaxoSmithKline |
| Name of the manufacturing country | Belgium |
| Year of manufacture | 2005 |
| Clinical Phase status | Clinical - Phase 2 |
| Bacterial strain | Gram-positive, facultative anaerobic bacteria. |
| Efficacy | NA |
| Vaccine formulation | NA |
| Dosage | Two doses. |
| Mechanism of action | NA |
| Route of administration | Intramuscular |
| Indications | NA |
| Export | NA |
| Approval | NA |
| Adjuvant | With or without adjuvant |
| Repurposing | For Invasive Pneumococcal diseases and Pneumonia |
| Side effects of vaccine | NA |
| Post vaccination | NA |
| Dose type | Combination doses |
| Interspecies transfer | NA |
| PubMed identifier | NA |
| Clinical trial number | NCT00307528 |
| Reference | NA |
| Other name | NA |
| Additional Links | NA |